Klarna Reports Tuesday With the Weakest BNPL Scorecard
Klarna (KLAR) reports second-quarter earnings Tuesday before the U.S. market opens, and heading into that report, its Stoxcraft scorecard is the weakest of the three major buy-now-pay-later names Stoxcraft tracks. Health Score sits at just 1.2 out of 10, Performance Score at 1.4, and Risk Score at 9.0, the highest of the group by a wide margin. Klarna's own investor relations site carries the full earnings schedule and prior quarterly filings.
The stock trades at $20.79, down 54.63% over the past 12 months even after a 37.05% rally over the past three months. RSI, a momentum gauge that flags a stock as overbought above 70, reads 62.20, moderately elevated but not stretched. The average analyst price target of $23.00 implies real upside from here, a reminder that Wall Street's earnings expectations and Stoxcraft's fundamentals-and-risk scoring aren't measuring the same thing.
Why Klarna's Health Score Sits at 1.2
The Health Score is where Klarna's numbers get hardest to argue with. Net loss of $241 million on $3.51 billion in revenue over the trailing year sits alongside operating cash flow of -$1.03 billion, meaning the core business is still burning real cash at scale, not just posting an accounting loss. Interest coverage sits at just 0.65, meaning operating income barely covers the interest bill on the company's $1.43 billion in total debt.
An Altman Z-Score of 0.75, a bankruptcy-risk gauge where anything below roughly 1.8 flags distress, puts Klarna well inside distress territory. Piotroski Score, a 9-point balance-sheet-quality checklist, reads just 1, among the weakest readings Stoxcraft tracks. Return on equity of -11.73% rounds out a picture of a company still spending heavily to grow, with the fundamentals not yet catching up.
Liquidity is the one area that isn't flashing red. Current ratio of 1.07 means Klarna can still cover its near-term obligations, just without much room to spare. Beta of 1.94 shows the stock moves nearly twice as sharply as the broader market in either direction, and standard deviation of 2.29% over recent sessions confirms shares have been genuinely choppy heading into Tuesday's report, not quietly drifting.
How Sezzle and Affirm Compare
Sezzle is the group's clear outlier on the strong side. Its 9.3 Health Score is built on genuine profitability: net income of $133 million on $450 million in revenue, a 78.40% return on equity, and an Altman Z-Score of 16.70 that puts distress risk essentially off the table. Sezzle's Performance Score of 8.9 comes with real volatility attached, though, RSI of 39.77 and a one-month decline of 28.53% show the stock has cooled sharply even as its three-year return sits above 7,000%. Sezzle's own investor relations site details the margin expansion behind those numbers.
Affirm sits squarely in the middle of the group on both Health and Performance, at 5.0 each, almost exactly the Stoxcraft universe median. Net income of $52 million on $3.22 billion in revenue marks a real shift from years of losses, though a P/E ratio of 432.13 shows the market is still pricing in a lot of future growth relative to today's thin profit. Affirm's Risk Score of 8.4 sits between Sezzle's 9.9 and Klarna's 9.0, all three names carrying real volatility even as their fundamentals diverge sharply. Affirm's own investor relations site lays out the loan book quality behind that improvement.
What Tuesday's Report Could Change
An earnings report doesn't rewrite a scorecard overnight, but it can shift the trajectory. A smaller-than-expected loss, a revenue beat, or guidance that points toward the cash burn narrowing would all be meaningful for a stock whose Health Score currently sits near the bottom of the entire Stoxcraft universe. The reverse is also true: another wide miss would reinforce, not create, the pattern the scorecard already shows.
What Tuesday's report won't change is the structural gap between Klarna and its two closest listed peers. Sezzle has already proven it can run a BNPL business at a 78.40% return on equity. Affirm has crossed into sustained profitability, even if thinly. Klarna's path to either outcome starts from a much deeper hole, an Altman Z-Score of 0.75 and a $1.03 billion annual cash burn, that one quarter's results won't fully close.
The three names also illustrate how differently the same underlying business model, letting shoppers split a purchase into installments, can play out on a balance sheet. Sezzle runs lean and keeps growth funded internally. Affirm has scaled into a much larger loan book and is only now seeing that scale translate into consistent profit. Klarna has scaled the fastest of the three by revenue, $3.51 billion against Sezzle's $450 million and a meaningful share of Affirm's $3.22 billion, but that growth has come without the operating discipline showing up yet in its scores. Revenue scale alone hasn't been enough to move Klarna's Health Score off the floor.
For a broader view of how KLAR, SEZL, and AFRM stack up against the rest of the Financial - Credit Services industry on Health, Performance, and Risk Score, the Stoxcraft Screener lets you filter the full industry by any of the three.
